[Abstract Only] Study: SGLT2 Inhibitors not Associated with Increased Risk of Severe Urinary Tract Infections

Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: SGLT-2 inhibitors not associated with increased risk for severe UTIs – ACP Diabetes (free) AND SGLT2 Inhibitor Use Not Linked to Increased Risk for UTI Events – Endocrinology Advisor (free) AND SGLT-2 inhibitors not associated with increased risk for severe UTI – 2 Minute Medicine (free)